6th Pan Pacific Connective Tissue Societies Symposium

描述（由申请人提供）： 第六届泛太平洋结缔组织协会研讨会将于 2005 年 11 月 30 日至 12 月 5 日在夏威夷大岛的希尔顿威可洛亚酒店举行。第六届研讨会的具体目标如下：（1）交流和分享有关已知和新型结缔组织成分的新成果，包括分子和结构生物学、组装和周转；体外和体内定义的细胞和发育功能和活动；细胞内机制和信号通路；以及动物和人类遗传性和获得性疾病中这些功能和过程的破坏； (2) 加强对结缔组织研究这些方面感兴趣的科学家之间的互动和合作，特别是那些在环太平洋国家工作的科学家； （三）为讨论新思想、新概念、新假设提供开放的论坛； (4) 通过提供一个计划，最大限度地提高受训者和新研究者与现有研究者的互动，鼓励该领域的受训者和新研究者； (5) 特别为新研究者提供展示数据、接收参与者最大反馈以及组织研讨会的机会； （6）促进抗体、细胞系、工程小鼠模型等试剂的交换； （七）汇聚基础研究组、临床研究组、医药生物技术企业的科学家； （八）营造有利于实现目标的氛围。由于多种原因，本次研讨会将特别重要。首先，我们组织了一个异常广泛且包含该领域当前主要研究兴趣的项目。其次，本次研讨会的议程强调 ECM 成分如何在三维 (3D) 功能结缔组织中相互作用。因此，本次研讨会将代表该领域的“前沿”研究，并将为相互作用组新后基因组时代的新兴概念做出贡献。第三，研讨会将突出几位西海岸科学家做出的重大贡献。第四，本次研讨会对于新研究者来说将是一次重要的会议。将举行 18 场正式会议，每场均由杰出科学家主持，并有时间由新研究人员进行额外演讲、2 场墙报会议和数场非正式研讨会。此外，还将有机会进行非正式讨论和活动，以促进参与者之间的互动。

DESCRIPTION (provided by applicant): The 6th Pan Pacific Connective Tissue Societies symposium will be held November 30-December 5, 2005, at the Hilton Waikoloa on the Big Island of Hawaii. The specific aims of the 6th Symposium are the following: (1) To communicate and share new results concerning known as well as novel connective tissue constituents, including molecular and structural biology, assembly, and turnover; cellular and developmental functions and activities defined in vitro and in vivo; intracellular mechanism and signaling pathways; and the disruption of these functions and processes in hereditary and acquired diseases in animals and humans; (2) To increase interactions and collaborations between scientists, especially those working in the Pacific Rim countries, interested in these aspects of connective tissue research; (3) To provide an open forum for the discussion of new ideas, new concepts, and new hypotheses; (4) To encourage trainees and new investigators in this area by providing a program that will maximize their interactions with established investigators; (5) To specifically afford opportunities to new investigators to present their data, to receive maximal feedback from participants, and to organize workshops; (6) To facilitate the exchange of reagents such as antibodies, cell lines, and engineered mouse models; (7) To bring together scientists from basic research groups, clinical research groups, and pharmaceutical and biotechnology companies; (8) To create an atmosphere conducive to achieve these aims. This Symposium will be especially significant for several reasons. First, we have organized a program that is unusually broad and inclusive of major current research interests in this area. Second, the program of this Symposium emphasizes how ECM constituents interact in three-dimensional (3D) functioning connective tissues. This Symposium will therefore represent "cutting edge" research in this area and will contribute to emerging concepts in the new post-genomic era of the interactome. Third, the Symposium will highlight the significant contributions made by several West Coast scientists. Fourth, the Symposium will be a significant meeting for new investigators. There will be 18 formal sessions, each chaired by outstanding scientists with time for additional presentations by new investigators, 2 poster sessions, and several informal workshops. In addition, there will be opportunities for informal discussions and activities to promote interactions between participants.